Stockscreener 앱 받기
9.165
1.61%
0.145
시간 외 거래:
9.22
0.055
+0.60%
전일 마감가:
$9.02
열려 있는:
$8.58
하루 거래량:
2.02M
Relative Volume:
1.08
시가총액:
$1.34B
수익:
-
순이익/손실:
$-174.61M
주가수익비율:
-4.6523
EPS:
-1.97
순현금흐름:
$-165.54M
1주 성능:
+0.05%
1개월 성능:
-7.89%
6개월 성능:
-19.68%
1년 성능:
+14.71%
1일 변동 폭
$8.4207
$9.21
1주일 범위
$8.4207
$10.32
52주 변동 폭
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
명칭
89 Bio Inc
전화
(415) 432-9270
주소
655 MONTGOMERY STREET, SAN FRANCISCO, CA
ETNB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
9.165 | 1.38B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-14 | 개시 | Goldman | Neutral |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-04-22 | 재개 | BofA Securities | Buy |
| 2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-06-13 | 개시 | Evercore ISI | Outperform |
| 2022-05-12 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-26 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-19 | 개시 | Raymond James | Strong Buy |
| 2020-09-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-07-23 | 개시 | BTIG Research | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2019-12-09 | 개시 | BofA/Merrill | Neutral |
| 2019-12-09 | 개시 | Oppenheimer | Outperform |
| 2019-12-09 | 개시 | RBC Capital Mkts | Outperform |
| 2019-12-09 | 개시 | SVB Leerink | Outperform |
모두보기
89 Bio Inc 주식(ETNB)의 최신 뉴스
Signal strength of 89bio Inc. stock in tech scannersFree Community Verified Stock Suggestions - Newser
What makes 89bio Inc. stock price move sharplyFree Low Risk Equity Screener With Results - Newser
Chart based exit strategy for 89bio Inc.Free Long Hold Safe Return Strategy - Newser
How moving averages guide 89bio Inc. tradingAI Trade Signal Forecast with Chart Logic - Newser
Statistical indicators supporting 89bio Inc.’s strengthFree High Yield Stock Screening Results - Newser
Using Bollinger Bands to evaluate 89bio Inc.Momentum Detection with Entry Optimization - Newser
Analyzing recovery setups for 89bio Inc. investorsSwing Trade Timing with Daily Forecast - Newser
What institutions are buying 89bio Inc. stock nowFree Pattern Alert With ROI Driven Strategy - Newser
89Bio Inc. Faces Financial Uncertainty Amid Potential U.S. Tax Law Changes - TipRanks
How 89bio Inc. stock performs during market volatilityHigh Probability Trade Outcome Prediction - Newser
Evaluating 89bio Inc. with trendline analysisTrading Opportunities Forecast by AI Insight - Newser
What moving averages say about 89bio Inc.Predictive System for Long-Term Stock Forecast - Newser
How to read the order book for 89bio Inc.Swing Trade Entry and Exit Point Analysis - Newser
89bio Inc. recovery potential after sell offFree High Return Stock Focus With Safety - Newser
89bio, Inc. SEC 10-Q Report - TradingView
Can trapped investors hope for a rebound in 89bio Inc.Free Real Time Alerts Based on AI Prediction - Newser
89Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
89bio (ETNB) Q2 R&D Jumps 131% - The Motley Fool
89Bio Inc.’s ENTRUST Study: A Potential Game-Changer in Hypertriglyceridemia Treatment - TipRanks
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates - The Manila Times
ETNB89Bio, Inc. Latest Stock News & Market Updates - Stock Titan
Advanced analytics toolkit walkthrough for 89bio Inc.Free Chart Driven High Reward Trading Setup - Newser
Quantitative breakdown of 89bio Inc. recent moveSwing Watchlist With Tight Stop Placement - Newser
Custom strategy builders for tracking 89bio Inc.Near-Term Market Opportunity Forecast Sheet - Newser
Can 89bio Inc. stock recover from recent declineEarly Entry Planner for Swing Candidates - Newser
Allianz Asset Management GmbH Invests $93,000 in 89BIO (NASDAQ:ETNB) - Defense World
How to monitor 89bio Inc. with trend dashboardsFree Capital Efficiency Optimized Stock Alerts - Newser
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
89bio Awards Major Stock Options Package: 267,000 Shares to 3 New Hires in Liver Disease Research Push - Stock Titan
Recovery Signals Appearing in 89bio Inc. ChartsCapital Efficiency Optimized Stock Alerts Reviewed - metal.it
89 Bio Inc (ETNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):